Vanguard Group’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,628,875
| Closed | -$287M | – | 4327 |
|
|
2024
Q4 | $287M | Buy |
5,628,875
+30,702
| +0.5% | +$1.57M | 0.01% | 1366 |
|
|
2024
Q3 | $231M | Sell |
5,598,173
-30,602
| -0.5% | -$1.26M | ﹤0.01% | 1473 |
|
|
2024
Q2 | $271M | Buy |
5,628,775
+28,921
| +0.5% | +$1.39M | 0.01% | 1324 |
|
|
2024
Q1 | $269M | Buy |
5,599,854
+561,562
| +11% | +$26.9M | 0.01% | 1343 |
|
|
2023
Q4 | $327M | Buy |
5,038,292
+325,586
| +7% | +$21.1M | 0.01% | 1234 |
|
|
2023
Q3 | $308M | Sell |
4,712,706
-36,096
| -0.8% | -$2.36M | 0.01% | 1188 |
|
|
2023
Q2 | $276M | Buy |
4,748,802
+352,398
| +8% | +$20.5M | 0.01% | 1292 |
|
|
2023
Q1 | $271M | Buy |
4,396,404
+64,975
| +2% | +$4.01M | 0.01% | 1279 |
|
|
2022
Q4 | $275M | Buy |
4,331,429
+88,191
| +2% | +$5.61M | 0.01% | 1243 |
|
|
2022
Q3 | $308M | Buy |
4,243,238
+242,983
| +6% | +$17.7M | 0.01% | 1115 |
|
|
2022
Q2 | $272M | Buy |
4,000,255
+481,609
| +14% | +$32.7M | 0.01% | 1242 |
|
|
2022
Q1 | $319M | Buy |
3,518,646
+416,425
| +13% | +$37.7M | 0.01% | 1259 |
|
|
2021
Q4 | $283M | Buy |
3,102,221
+200,989
| +7% | +$18.3M | 0.01% | 1388 |
|
|
2021
Q3 | $235M | Buy |
2,901,232
+387,349
| +15% | +$31.4M | 0.01% | 1505 |
|
|
2021
Q2 | $234M | Buy |
2,513,883
+433,521
| +21% | +$40.4M | 0.01% | 1537 |
|
|
2021
Q1 | $223M | Buy |
2,080,362
+540,393
| +35% | +$57.8M | 0.01% | 1526 |
|
|
2020
Q4 | $134M | Buy |
1,539,969
+714,040
| +86% | +$62.3M | ﹤0.01% | 1680 |
|
|
2020
Q3 | $57M | Buy |
825,929
+316,184
| +62% | +$21.8M | ﹤0.01% | 1945 |
|
|
2020
Q2 | $24.7M | Buy |
+509,745
| New | +$24.7M | ﹤0.01% | 2318 |
|